Pfizer's Avastin biosimilar wins FDA approval
Pfizer Inc said on Friday that the U.S. Food and Drug Administration had approved its biosimilar to Roche Holding AG's blockbuster cancer treatment Avastin.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Pfizer